Indice
Descrizione indicatore
L’indicatore ci consente di calcolare il numero di interventi chirurgici di valvuloplastica o sostituzione di valvola eseguiti in un anno in una struttura ospedaliera (indicatore di "volume").
Come si legge
L’indicatore si riferisce al grado di “competenza” delle cure prestate.
Più alto è il numero di interventi chirurgici di valvuloplastica o sostituzione di valvola eseguiti in una struttura ospedaliera, maggiore è il grado di esperienza della struttura stessa.
Non costituisce un parametro di valutazione inerente l’esito delle cure prestate.
Descrizione generale
La chirurgia sulle valvole cardiache permette di riparare o sostituire valvole stenotiche oppure non continenti (insufficienti).
Quando la riparazione non è possibile, si deve procedere alla sostituzione con valvole meccaniche o biologiche (animali oppure eterologhe).
In caso di sostituzione con valvola meccanica è necessario somministrare al paziente una terapia anticoagulante a lungo termine per evitare la formazione di coaguli. La terapia anticoagulante potrebbe non essere necessaria in caso di sostituzione con valvola biologica, che ha però una durata limitata ed è, pertanto, indicata per pazienti anziani, per donne in età fertile in aspettativa di gravidanza oppure per pazienti con controindicazioni alla terapia anticoagualante.
Codici ICD-9-CM selezionati
Fonte del dato
Programma Nazionale Esiti 2022, indicatore 121.
Confronto tra strutture calcolato su dati 2021.
Nota bene: Per tener conto di errori di attribuzione, sono escluse dall'analisi le strutture con volumi di attività molto bassi (min 5/anno).
Altre fonti scientifiche
- Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW; STS; AATS; EACTS. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg. 2008 Apr;85(4):1490-5.
- Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic simple risk stratification model for heart valve surgery. Circulation 2005;112:224 –31.
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006 Aug 1;114(5):e84-231.
- Böning A, Boedeker RH, Rosendahl UP, Niemann B, Haberer S, Roth P, Ennker JA. Long-term Results of Mechanical and Biological Heart Valves in Dialysis and Non-Dialysis Patients. Thorac Cardiovasc Surg. 2011 May 3.
- Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885–92.
- El-Hamamsy I, Ibrahim M, Stevens LM, Witzke H, Clark L, Yacoub MH. Early and long-term results of reoperative total aortic root replacement with reimplantation of the coronary arteries. J Thorac Cardiovasc Surg. 2011 May 7.
- Florath I, Rosendahl UP, Mortasawi A, et al. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg 2003; 76:75– 83.
- Gardner SC, Grunwald GK, Rumsfeld JS, et al. Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery. Ann Thorac Surg 2004;77:549 –56.
- Hannan EL, Racz MJ, Jones RH, et al. Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg 2000;70:1212– 8.
- Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, Higgins RS, Smith CR, Jones RH. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg. 2007 Mar;83(3):921-9.
- Hawkins RB, Downs EA, Johnston LE, Mehaffey JH, Fonner CE, Ghanta RK, Speir AM, Rich JB, Quader MA, Yarboro LT, Ailawadi G; Investigators for the Virginia Cardiac Services Quality Initiative. Impact of Transcatheter Technology on Surgical Aortic Valve Replacement Volume, Outcomes, and Cost. Ann Thorac Surg. 2017 Jun;103(6):1815-1823. doi: 10.1016/j.athoracsur.2017.02.039.
- Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Ann Thorac Surg 1999; 67:943-51.
- Jin R, Grunkemeier GL, Starr A, for the Providence Health System Cardiovascular Study Group. Validation and refinement of mortality risk models for heart valve surgery. Ann Thorac Surg 2005;80:471–9.
- Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)1; European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012 Oct;33(19):2451-96.
- Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Mar 3.
- Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004;77:1966 –77.
- Shi JH, Meng X, Han J, Li Y, Wang JG, Zhang HB, Jia YX, Gurbanov E, Zhuang XJ. A mortality risk assessment model for cardiac valve replacement surgery and its application in the use of prophylactic extracorporeal membrane oxygenation. Int Surg. 2010 Jul-Sep;95(3):227-31.
- Tamburino C, Barbanti M, Capodanno D, Sarkar K, Cammalleri V, Scarabelli M, Mulè M, Immè S, Aruta P, Ussia GP. Early and mid term outcomes of transcatheter aortic valve implantation in patients with logistic euroscore less than 20%: A comparative analysis between different risk strata. Catheter Cardiovasc Interv. 2011 Apr 28.
- Verma DR, Pershad Y, Lazkani M, Fang K, Morris M, Pershad A. Volume-outcome relationships for transcatheter aortic valve replacement-risk-adjusted and volume stratified analysis of TAVR outcomes. Indian Heart J. 2017 Nov - Dec;69(6):700-706. doi: 10.1016/j.ihj.2017.04.017.
- Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, Miller VM, Nishimura RA. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017 Dec 19;70(24):2953-2960. doi: 10.1016/j.jacc.2017.10.039.